The request to recreate a Monte Carlo simulation in Excel is not a niche ask. It is a direct reflection of how the industry is quietly changing, and we think that change is long overdue. The user, who clearly understands the statistical language of clinical trials, is not looking for a shortcut. They are looking for a way to make the mechanics tangible, to move beyond the abstract and into the operational. That desire to tinker, to build, and to test assumptions is exactly the mindset that will define the next generation of data professionals.
For the reader, this is about more than just learning a new spreadsheet trick. The practical value here is immense. If you have ever had to explain a probability of success calculation to a stakeholder, you know that citing a number is not enough. They want to see the logic, the inputs, and the sensitivity. By building this model yourself, you gain the ability to stress-test the assumptions, to change the alpha allocation, or to shift the hazard ratio and see the immediate impact. This is not about replacing the biostatistician; it is about empowering the analyst to ask better questions. The user's specific questions about simulating time-to-event data and linking it to interim analysis are the exact building blocks that turn a static report into a dynamic decision-making tool.
What is particularly compelling is the humility in the request. The user is not claiming to reinvent the wheel. They are asking for pointers, templates, and resources. This is the correct approach. The field of clinical trial modeling is complex, but the tools to engage with it are becoming more accessible. We believe that accessible Monte Carlo modeling will not dumb down the process; it will democratize it. It allows more people to participate in the conversation, to challenge the assumptions, and to understand the risk profile of a trial. The fact that this is being done in Excel is a testament to its ubiquity and flexibility, not a limitation.
Our advice is straightforward. Start with a simple exponential survival model, even if it feels too basic. Get the mechanics of the event generation working first. Then, layer in the complexity of the interim analysis and alpha spending. Do not try to build the entire model in one sitting. Break it down into its component parts, as the user has done, and tackle each one sequentially. The goal is not to produce a publication-ready simulation on the first try. The goal is to build a working understanding of how the pieces fit together. When you can simulate a trial and see the probability of success move in response to your inputs, you will never read an equity research report the same way again. That is the point where the learning sticks.